Cargando…
Dangers of hyperoxia
Oxygen (O(2)) toxicity remains a concern, particularly to the lung. This is mainly related to excessive production of reactive oxygen species (ROS). Supplemental O(2), i.e. inspiratory O(2) concentrations (F(I)O(2)) > 0.21 may cause hyperoxaemia (i.e. arterial (a) PO(2) > 100 mmHg) and, subseq...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686263/ https://www.ncbi.nlm.nih.gov/pubmed/34924022 http://dx.doi.org/10.1186/s13054-021-03815-y |
_version_ | 1784617981268983808 |
---|---|
author | Singer, Mervyn Young, Paul J. Laffey, John G. Asfar, Pierre Taccone, Fabio Silvio Skrifvars, Markus B. Meyhoff, Christian S. Radermacher, Peter |
author_facet | Singer, Mervyn Young, Paul J. Laffey, John G. Asfar, Pierre Taccone, Fabio Silvio Skrifvars, Markus B. Meyhoff, Christian S. Radermacher, Peter |
author_sort | Singer, Mervyn |
collection | PubMed |
description | Oxygen (O(2)) toxicity remains a concern, particularly to the lung. This is mainly related to excessive production of reactive oxygen species (ROS). Supplemental O(2), i.e. inspiratory O(2) concentrations (F(I)O(2)) > 0.21 may cause hyperoxaemia (i.e. arterial (a) PO(2) > 100 mmHg) and, subsequently, hyperoxia (increased tissue O(2) concentration), thereby enhancing ROS formation. Here, we review the pathophysiology of O(2) toxicity and the potential harms of supplemental O(2) in various ICU conditions. The current evidence base suggests that PaO(2) > 300 mmHg (40 kPa) should be avoided, but it remains uncertain whether there is an “optimal level” which may vary for given clinical conditions. Since even moderately supra-physiological PaO(2) may be associated with deleterious side effects, it seems advisable at present to titrate O(2) to maintain PaO(2) within the normal range, avoiding both hypoxaemia and excess hyperoxaemia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03815-y. |
format | Online Article Text |
id | pubmed-8686263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86862632021-12-20 Dangers of hyperoxia Singer, Mervyn Young, Paul J. Laffey, John G. Asfar, Pierre Taccone, Fabio Silvio Skrifvars, Markus B. Meyhoff, Christian S. Radermacher, Peter Crit Care Review Oxygen (O(2)) toxicity remains a concern, particularly to the lung. This is mainly related to excessive production of reactive oxygen species (ROS). Supplemental O(2), i.e. inspiratory O(2) concentrations (F(I)O(2)) > 0.21 may cause hyperoxaemia (i.e. arterial (a) PO(2) > 100 mmHg) and, subsequently, hyperoxia (increased tissue O(2) concentration), thereby enhancing ROS formation. Here, we review the pathophysiology of O(2) toxicity and the potential harms of supplemental O(2) in various ICU conditions. The current evidence base suggests that PaO(2) > 300 mmHg (40 kPa) should be avoided, but it remains uncertain whether there is an “optimal level” which may vary for given clinical conditions. Since even moderately supra-physiological PaO(2) may be associated with deleterious side effects, it seems advisable at present to titrate O(2) to maintain PaO(2) within the normal range, avoiding both hypoxaemia and excess hyperoxaemia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03815-y. BioMed Central 2021-12-19 /pmc/articles/PMC8686263/ /pubmed/34924022 http://dx.doi.org/10.1186/s13054-021-03815-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Singer, Mervyn Young, Paul J. Laffey, John G. Asfar, Pierre Taccone, Fabio Silvio Skrifvars, Markus B. Meyhoff, Christian S. Radermacher, Peter Dangers of hyperoxia |
title | Dangers of hyperoxia |
title_full | Dangers of hyperoxia |
title_fullStr | Dangers of hyperoxia |
title_full_unstemmed | Dangers of hyperoxia |
title_short | Dangers of hyperoxia |
title_sort | dangers of hyperoxia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686263/ https://www.ncbi.nlm.nih.gov/pubmed/34924022 http://dx.doi.org/10.1186/s13054-021-03815-y |
work_keys_str_mv | AT singermervyn dangersofhyperoxia AT youngpaulj dangersofhyperoxia AT laffeyjohng dangersofhyperoxia AT asfarpierre dangersofhyperoxia AT tacconefabiosilvio dangersofhyperoxia AT skrifvarsmarkusb dangersofhyperoxia AT meyhoffchristians dangersofhyperoxia AT radermacherpeter dangersofhyperoxia |